Redmile Group, LLC - Dec 31, 2024 SCHEDULE 13G/A Report for Neurogene Inc. Common Stock, $0.000001 par value (NGNE)

Filing Manager
Redmile Group, LLC
Reporting Manager
Redmile Group, LLC
Security
Neurogene Inc. Common Stock, $0.000001 par value
Symbol
NGNE
Shares outstanding
14.9M shares
Disclosed Ownership
1.48M shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 08:01 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Redmile Group, LLC 9.9% 1.48M 0 1.48M /s/ Jeremy C. Green Managing Member
Jeremy C. Green 9.9% 1.48M 0 1.48M /s/ Jeremy C. Green Jeremy C. Green
Redmile Biopharma Investments I, L.P. 5.4% 812K 0 812K /s/ Jeremy C. Green Managing Member of Redmile Group, LLC, managing member of Redmile Biopharma Investments I (GP), LLC, GP of Redmile Biopharma Investments I, L.P.